HealthHighSingle-source
7.5
Novartis' Pelacarsen Fails Major Heart Disease Trial, Shocking Cardiologists
New York Times·US · CH·about 4 hours ago
A health expert highlights that estrogen deficiency during perimenopause (ages 40-50) increases cardiovascular disease risk, as estrogens protect cardiovascular and neurological health. The claim is a general medical observation, not a new study or event. It reinforces established medical knowledge, with no new data or policy implications.